Esperion Therapeutics, Inc. (Nasdaq: ESPR) is a commercial-stage pharmaceutical company based in Ann Arbor, Michigan, focused on discovering, developing, and commercializing innovative medicines that lower LDL cholesterol and reduce cardiovascular risk. - View it on GitHub